Skip to content

Isabella Caroline Da Silva Dias

Universidade de São Paulo

2 papers in the library · 19 citations · publishing 2022-2025

Papers

Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability

Expert Opinion on Drug Safety March 18, 2022 Giordano Novak Rossi, Isabella Caroline Da Silva Dias, Glen B. Baker et al. 17 citations

In controlled settings, ayahuasca administration appears relatively safe, with no serious adverse events reported. Common side effects include nausea, vomiting, headaches, and temporary increases in heart rate and blood pressure. Research on ayahuasca's antidepressant effects is still early, lacking large, robust clinical trials. Major obstacles to its therapeutic use include dose standardization, legal prohibition of its alkaloids, and questions about compensating traditional communities if ayahuasca becomes an approved medicine.

Clinical pharmacology of ayahuasca: potential applications and future considerations

Expert Review of Clinical Pharmacology October 3, 2025 Lorena Terene Lopes Guerra, Isabella Caroline Da Silva Dias, Jaime E. C. Hallak et al. 2 citations

Whether subjective experience contributes to therapeutic mechanisms of ayahuasca is debated and may depend on the targeted condition. Few controlled studies exist, limiting conclusions on safety and efficacy. Ayahuasca's highly variable composition poses an additional challenge, prompting studies using isolated compounds.